dr. chavez discusses ibrutinib plus venetoclax in cll
Published 7 years ago • 309 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
0:41
dr. chavez on combination of ibrutinib plus ublituximab in cll
-
2:04
dr. chavez on ongoing efficacy and challenges with ibrutinib in cll
-
1:36
dr. logan discusses ibrutinib plus venetoclax in cll
-
1:16
dr. wierda on ibrutinib plus venetoclax in cll
-
0:54
dr. davids discusses ongoing research with ibrutinib plus venetoclax in cll
-
1:02
dr. gerson on venetoclax/obinutuzumab combination in cll
-
1:05
dr. smith on using venetoclax versus ibrutinib in cll
-
1:23
captivate: fixed-duration ibrutinib plus venetoclax in patients with cll/sll
-
2:43
outcomes in high-risk cll patients following fixed-duration treatment with ibrutinib plus venetoclax
-
1:56
ibrutinib plus venetoclax for first-line treatment of cll: 4-year follow-up data
-
1:09
majic: venetoclax with acalabrutinib or obinutuzumab in cll
-
6:14
ibrutinib plus venetoclax for treatment of cll (chronic lymphocytic leukemia) - asco 2022
-
1:00
dr. smith on ibrutinib-based therapies in cll
-
4:07
management of cll progression after ibrutinib
-
1:25
dr. rogers discusses obinutuzumab, ibrutinib, and venetoclax combination in cll
-
1:21
dr. pleyer on ongoing research with ibrutinib plus venetoclax in cll
-
3:01
ibrutinib venetoclax for cll
-
0:56
dr. al-sawaf on continual mrd assessment after venetoclax/obinutuzumab in cll
-
1:54
glow: assessing ibrutinib plus venetoclax in cll